The present study reanalyzed publicly available RNA-seq data from human breast tumors and normal tissues to identify DEGs and to investigate functional enrichment, identifying differences in expression between tumor and normal samples, but no KEGG pathway reached the set FDR significance threshold.
Reference genome and transcriptome are fundamental components of RNA-seq analysis and can influence transcript quantification and downstream differential expression results. Although GRCh38 is the current human reference build, GRCh37 remains in use in research and clinical bioinformatics workflows. The extent to which...
Paweł Zieliński, M. Frąszczak, Bartosz Czech et al.· International Journal of Mol...· 0 citations
Differential gene expression analysis is a powerful technique to characterize biological systems. Differentially expressed genes (DEGs) are commonly identified by analysis of RNA sequencing datasets or mass spectrometry proteomics datasets. Increasingly, multi-omic studies include both RNA sequencing and proteomics fro...
Xi-Jun Zhang, Joseph P. LaMorte, Robert L. Kortum et al.· bioRxiv· 0 citations
Background/Objectives: Reference genome choice can introduce systematic bias into cancer transcriptomic analyses, particularly for populations underrepresented in standard references. However, its impact on downstream biological interpretation remains insufficiently characterized. Methods: We compared GRCh38, T2T-CHM13...
This study demonstrates that integrating two independent RNA-seq analytical workflows enables the identification of robust and clinically meaningful gene signatures in breast cancer, and provides a systematic approach for prioritizing candidate biomarkers and therapeutic targets in cancer transcriptomics.
It is indicated that a reproducible, strongly immune/interferon-skewed transcriptional signature, rather than a balanced up/down transcriptional shift, characterizes the mouse AD models analyzed here.
The identified 16 hub genes and associated miRNA-mRNA axes point to potential molecular mechanisms underlying the malignancy of LGG into HGG and identify promising biomarkers and therapeutic targets for this devastating disease.
H. Xiang, Hong-Li Zhang, O. Beylerli et al.· Current Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.